Who
Jonathan Schechter
Director
Company insider
Files Form 4 as: Director, PharmaCyte Biotech; Director, TaoWeave; Director, Tao Synergies; Director, Neurotrope.
In numbers
- Trades disclosed
- 46
- Buys
- 10
- Sells
- 1
- Bought
- $236K
- Sold
- $24K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 13 Dec 2018
- Last trade
- 31 Mar 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Mar 2026filed 17 Jul 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code J | —0 | filing |
| 31 Mar 2026filed 17 Jul 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code J | —0 | filing |
| 31 Mar 2026filed 2 Apr 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —119,170 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —119,170 at $0.00 | filing |
| 7 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $17K20,000 at $0.8436 | filing |
| 7 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $17K20,000 at $0.84 | filing |
| 6 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $16K20,000 at $0.7904 | filing |
| 6 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $16K20,000 at $0.79 | filing |
| 5 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $16K20,000 at $0.7776 | filing |
| 5 Jan 2026filed 7 Jan 2026 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Bought | $16K20,000 at $0.78 | filing |
| 12 Dec 2025filed 12 Dec 2025 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 12 Dec 2025filed 12 Dec 2025 | PMCB PharmaCyte BiotechBiotechnology | SEC FORM 4 Code F | $69K67,500 at $1.02 | filing |
| 14 Nov 2025filed 17 Nov 2025 | TWAV TaoWeaveIT Services & Consulting | SEC FORM 4 Bought | $19K10,000 at $1.91 | filing |
| 17 Sep 2025filed 17 Sep 2025 | TWAV TaoWeaveIT Services & Consulting | SEC FORM 4 Bought | $14K5,000 at $2.70 | filing |
| 16 Sep 2025filed 16 Sep 2025 | TWAV TaoWeaveIT Services & Consulting | SEC FORM 4 Bought | $27K10,000 at $2.73 | filing |
| 6 Aug 2025filed 17 Oct 2025 | TAOX Tao Synergiesoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | TAOX Tao SynergiesConsumer & Specialty Finance | SEC FORM 4 Code A | —21,575 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | TAOX Tao SynergiesConsumer & Specialty Finance | SEC FORM 4 Code F | $68K8,630 at $7.85 | filing |
| 25 Apr 2025filed 12 Dec 2025 | PMCB PharmaCyte Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,233 at $0.00 | filing |
| 3 Apr 2025filed 7 Apr 2025 | TAOX Tao Synergiesoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —800 at $0.00 | filing |
News
Contrasting Currenc Group (NASDAQ:CURR) and TaoWeave (NASDAQ:TWAV)TWAV · themarketsdaily.com · 17 Oct 2026Critical Contrast: TaoWeave (NASDAQ:TWAV) vs. Currenc Group (NASDAQ:CURR)TWAV · dailypolitical.com · 15 Oct 2026PharmaCyte Biotech (OTCMKTS:PMCBD) Shares Down 2% – Here's WhyPMCB · dailypolitical.com · 10 Oct 2026TaoWeave, Inc.: TaoWeave Portfolio Company Manako Labs Goes Live With Avia Across 124 Unmanned Fuel Stations in FranceTWAV · finanznachrichten.de · 7 Oct 2026
0 headlines in the last 90 days name Jonathan Schechter; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.